Search This Blog

Tuesday, August 15, 2023

Be Aware: Someone could steal your medical records and bill you for their care

After HCA Healthcare announced last month that the personal identification data of roughly 11 million HCA patients in 20 states had been exposed in a breach, people may be justifiably concerned that their own medical data and identities could be stolen.

Consumers should realize that such “medical identity” fraud can happen in several ways, from a large-scale breach to individual theft of someone’s data.

Just ask Evelyn Miller. The first sign something was amiss was a text Miller received from an Emory University Hospital emergency department informing her that her wait time to be seen was 30 minutes to one hour. That’s weird, she thought. She no longer lives in Atlanta and hadn’t used that hospital system in years. Then she got a second text, similar to the first. Must be spam, she thought.

When she got a call the next day from an Emory staffer named Michael to discuss the diagnostic results from her ER visit, she knew something was definitely wrong. “It amazed me someone could get registered with another person’s name and no ID was checked or anything,” Miller said.

And while the name and date of birth the staffer had on record for her were correct, Miller’s address was not. She now lives in Blairsville, Georgia, a few hours north of Atlanta. Michael said he’d correct the problem. The next week, she got a bill from Emory for more than $3,600.

After an unsatisfactory conversation with someone in the hospital’s billing department, Miller sent a letter to the hospital’s privacy officer. Miller recalled writing: “I think there’s something going on, that someone is using my information, and the visit and the charges appear to be fraudulent.”

When contacted, Emory Healthcare spokesperson Janet Christenbury declined to comment on Miller’s case specifically but did say, “We take these matters seriously and work with our teams to ensure our processes and procedures are followed.”

Miller, 63, a retired health care administrator, was savvier than many about what might have occurred. The average person may have no idea a problem like this can arise until long after a theft occurs.

“The majority of victims find out when they’re trying to move on with their lives, if bills have gone to collections,” said Eva Velasquez, president and CEO of the Identity Theft Resource Center, a nonprofit that provides free assistance to victims of identity theft. Someone may apply for a mortgage, for example, and learn their credit is ruined due to unpaid medical bills for care they didn’t receive.

It’s a double whammy. Unlike other forms of identity fraud, medical identity thieves may steal not only their victims’ personal data – Social Security number, date of birth, address – but also information about their medical records and care, potentially putting their health at risk.

“Sometimes people can’t get their prescriptions, if their records are mixed with someone else’s,” Velasquez said. “Maybe you won’t be able to get treatment that you need. There are serious implications.”

A theft may affect just one person whose insurance card gets stolen or “borrowed” to pay for health care, or it may result from a data breach, as HCA Healthcare experienced. Such large-scale breaches are more likely to be used in financial fraud schemes than to get medical care, experts say.

Compared with other types of identity fraud, medical identity theft is rare. In 2022, for example, the Federal Trade Commission received 27,821 reports of medical identity theft, while reports for identity theft related to new credit card accounts totaled more than 400,000.

Medical identity theft also presents itself in different ways.

One Thief, One Victim
If someone gets ahold of another person’s health insurance number and driver’s license or other ID, they may be able to use it to receive medical services in someone else’s name.

Busy hospital emergency departments may make an attractive target for fraudsters. Procedures typically require patients to present insurance and photo identification information at check-in, said Rade Vukmir, an emergency physician in Pittsburgh and a spokesperson for the American College of Emergency Physicians. But these also don’t want to put people off from getting care, and people who are uninsured or disadvantaged might not have those documents.

“We want to treat that population,” he said. “We’re America’s safety net. We always provide care.”

Medical identity theft can happen if someone loses a wallet with their insurance card in it, for example, or a piece of mail from their insurer goes astray. But it doesn’t occur only among strangers. The victim often knows the thief and may even be in on the “friendly fraud,” as it’s called. According to one study, nearly half of people who failed to report medical identity theft said it was because they knew the thief.

For example, one person might have a higher copayment for emergency department visits, Vukmir said, so they let a family member, such as a cousin or a sibling, use their insurance card to get medical care.

“Usually, in those cases, it wasn’t an emergency,” said Vukmir.

Gangs of Thieves, Millions of Victims
In 2022, 707 health care data breaches affected nearly 52 million patients, according to an analysis of data from the Department of Health and Human Services’ Office for Civil Rights by the HIPAA Journal, which tracks compliance with health care data privacy law. Under federal law, health care organizations must notify individuals when their medical data has been exposed through a breach.

The largest health care data breach to date occurred in 2015, when nearly 80 million Anthem records were exposed. Though the 2022 figures for incidents among all health plans were slightly lower than the year before, there has been a clear upward trend in recent years in breaches, which are typically caused by hacking or IT incidents.

The American Hospital Association is “very concerned” about foreign-based hacking groups from countries like Russia, China, North Korea, and Iran, said John Riggi, the national adviser for cybersecurity and risk for the American Hospital Association.

Riggi said the personal information in people’s medical records may be sold in bulk to criminals who create phony providers to submit fraudulent claims on a mass scale that can result in hundreds of millions of dollars in Medicaid, Medicare, or other insurance fraud. Or they may use the information to create fake identities to apply for loans, mortgages, or credit cards.

“They flee with the money, and the individual is left to deal with it,” Riggi said.

Health plans could take lessons from the financial services industry to detect red flags, Riggi said. Financial institutions have sophisticated algorithms to identify purchasing and other patterns that are out of the ordinary, Riggi said. In health care, such mechanisms could be used to flag claims in which a provider is located more than 1,000 miles from where a patient lives, for example, or sees a patient for conditions that don’t jibe with their age or health status.

AHIP, an insurance industry trade group, didn’t respond to requests for comment.

What Consumers Can Do
Consumers should generally monitor the notices and bills they receive from insurers and providers and contact them immediately about anything suspicious.

In Miller’s case, it’s unclear whether her problem was due to an administrative snafu, such as another patient with the same name, or medical identity theft. But within a month of her initial call, the hospital removed the charges and assured her that her medical record had been disentangled from the other patient’s.

Other steps to take:
• Go to the FTC’s identity theft site to learn about next steps and file an identity theft report, if appropriate.

• If someone has used your name, contact every provider who may have been involved and ask for a copy of your medical records, then report any errors to your medical providers.

• Notify your health plan’s fraud department and send a copy of the FTC identity theft report.

• File free fraud alerts with the three major credit reporting agencies and get free credit reports from them. Consider filing a police report. If your health plan offers free credit or identity theft monitoring following a breach, take advantage of it.

“It’s best to proceed as if your data has been compromised and will be for sale,” said Velasquez, whose organization offers free assistance in recovering from identity theft. “Don’t be afraid to ask for help.”

http://www.louisianaweekly.com/be-aware-someone-could-steal-your-medical-records-and-bill-you-for-their-care/

Yellen admits to eating 'hallucinogenic' mushrooms during China visit

 Treasury Secretary Janet Yellen ate hallucinogenic mushrooms during her recent visit to China, she announced Monday.

Yellen ate the mushrooms as part of a meal at popular Chinese restaurant chain Yi Zuo Yi Wang (In and Out). She said she was not aware at the time that the dish included psychedelic mushrooms, but it soon became clear.

"So I went with this large group of people and the person who had arranged our dinner did the ordering," Yellen told CNN. "There was this delicious mushroom dish. I was not aware that these mushrooms had hallucinogenic properties."

"I learned that later," she added.

"I read that if the mushrooms are cooked properly, which I’m sure they were at this very good restaurant, that they have no impact," Yellen continued. "But all of us enjoyed the mushrooms, the restaurant, and none of us felt any ill effects from having eaten them."

Yellen met with Chinese officials in Beijing in early July in an effort to stabilize economic ties through "candor" and "respect." She and her counterparts discussed "significant disagreements," but she nevertheless described her trip as a success at the time.

"There are challenges, but I believe there is a desire on both sides to stabilize the relationship and to constructively address problems that each of us see in our relationship, to do so frankly, with candor, with respect, and to build a productive relationship going forward," she said.

Yellen speaks at Beijing press conference

Treasury Secretary Janet Yellen worked to stabilize economic ties with China during a trip to Beijing last month. (Mark Schiefelbein / AP Newsroom)

The mushrooms in question are known regionally as jian shou qing (see hand blue) mushrooms. In addition to their hallucinogenic properties, the mushrooms are known for turning a bluish color when touched by hand.

The mushrooms have been known to cause days-long hallucinations, but the effect varies from person to person. They are safe to eat when cooked properly.

Yellen returned from her trip to Beijing July 11, and she has played a major role in President Biden's economics plan, known as "Bidenomics."

https://www.foxbusiness.com/politics/treasury-secretary-janet-yellen-admits-eating-hallucinogenic-mushrooms-china-visit-delicious

AIM ImmunoTech Q2 updates

 

  • Ampligen identified as one of two potential therapeutics possessing modest to high potential for the treatment of post-COVID conditions out of 22 identified on-going randomized clinical trials in recent peer-reviewed publication.

  • Received updated data from Early Access Program (EAP) at Erasmus Medical Center which bolsters previously published data indicating that treatment with Ampligen following FOLFIRINOX was associated with improved survival rates in pancreatic cancer patients compared to matched controls of patients who did not receive Ampligen.

  • Commenced and completed full enrollment in the Company’s Phase 2 study evaluating Ampligen as a potential therapeutic for people with post-COVID conditions (AMP-518).

  • Announced the publication of pre-clinical data that suggests Ampligen has the potential to act directly on tumor cells to reduce tumor cell growth in pancreatic cancer patients with sufficient tumor levels of TLR-3, suggesting a potential biomarker to identify patients who may respond to Ampligen. The anti-tumor analysis was published in the peer-reviewed journal American Journal of Cancer Research in the paper “Rintatolimod: A potential treatment in patients with pancreatic cancer expressing Toll-like receptor 3.”

  • Announced the opening of an additional clinical trial site at University of Nebraska for Phase 2 study of Ampligen for the treatment of pancreatic cancer (AMP-270).

  • Granted patent No. 2022/01079, titled “Compositions and Methods Useful for Ebola Virus Infection” by the South African Patent and Trademark Office (CIPC).

Ampligen Expected Upcoming Pipeline Milestones

Q3 2023

  • Locally Advanced Pancreatic Cancer: Enroll and dose first patient in Phase 2 study

  • Advanced Recurrent Ovarian Cancer: Announce protocol-planned interim results

Q4 2023

  • Metastatic Pancreatic Cancer: Enroll and dose first patient in Phase 1b/2 study evaluating Ampligen in combination with AstraZeneca’s Imfinzi (durvalumab)

Conference Call and Webcast Details

As previously announced, the Company will host a quarterly conference call and live audio webcast to discuss the operational and financial results on August 15, 2023, at 8:30 AM ET.

The call will be hosted by members of AIM, CEO Thomas K. Equels and Scientific Officer Christopher McAleer, PhD. Interested participants and investors may access the conference call by dialing (877) 407-9219 (domestic) or (201) 689-8852 (international) and referencing the AIM ImmunoTech Conference Call. The live webcast will be accessible on the Events page of the Investors section of the Company’s website, aimimmuno.com, and will be archived for 90 days following the live event.

https://finance.yahoo.com/news/aim-immunotech-reports-second-quarter-104500363.html

At-home health test maker Thorne explores sale

 Thorne HealthTech Inc, a provider of at-home health tests and nutritional supplements, is exploring a sale, according to people familiar with the matter.

The New York-based company is working with investment bank CG Sawaya Partners as it fields interest from other companies and private equity firms, the sources said.

The sources, who asked not to be identified because the matter is confidential, added that no deal is certain. A Thorne spokesperson said the company does not comment on rumors or speculation. CG Sawaya did not respond to requests for comment.

Thorne's shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million. They are up 63.9% year-to-date, outperforming an 18.2% rise in the S&P 500 Index.

Founded in 1984, Thorne listed on the stock market in 2021 after it acquired Onegevity, a health analytics platform co-founded by Thorne Chief Executive Paul Jacobson.

The company provides at-home health tests to assess - and supplements to aid - sleep, fertility, stress, gut health and other areas to create a personalized wellness plan. It sells its products directly to consumers, rather than relying on retailers and e-commerce firms.

Thorne's at-home tests compete with Hims & Hers Health Inc, 23andMe Holding Co and Livongo Health Inc, while its rivals in the nutritional supplements market include Nestle Health Science and Metagenics.

Thorne has projected net sales of between $280 million and $290 million in 2023, up from $228.7 million in 2022, and adjusted earnings before interest, taxes, depreciation and amortization of $30 million to $32 million in 2023, up from $24.5 million in 2022.

Thorne's top shareholders are Japanese firms Kirin Holdings Co Ltd and Mitsui & Co Ltd, each with a 29% stake.

Kirin, one of Japan's major beer makers, has already shown an interest in taking over companies in the nutraceutical sector. In April, it acquired Australian vitamin Blackmores for $1.2 billion.

https://www.yahoo.com/lifestyle/exclusive-home-health-test-maker-152848001.html

Ukraine's Military Resources Are "Almost Exhausted", Russian Defense Chief Says

 Russia's defense minister Sergei Shoigu in fresh remarks before a security conference in Moscow acknowledged that while the special military operation in Ukraine has been a real test for Russia, the reality is that Ukraine's ability to fight and its resources have been "almost exhausted"

He further said the Russian military has learned much about the West's advanced weapons systems in the process. "In the special military operation, the Russian army has debunked many myths about the superiority of Western military standards," he said in the rare public speech, as cited in Reuters.

"The preliminary results of combat operations show that Ukraine's military resources are almost exhausted," he emphasized at one point, but without providing further specifics.

Importantly, China's own defense chief, Li Shangfu, was in the audience for the event. The Kremlin has recently said that a Putin trip to Beijing to meet with President Xi Jinping is "on the agenda", to happen by year's end.

Shoigu during the speech touted the large numbers of Western-supplied tanks and armored vehicles that have been taken out on the Ukrainian battlefield. 

"We have data on … the destruction of German tanks, American armored vehicles, British missiles and other weapons systems," he said. "We are ready to share our assessments ... with our partners." 

Likely he had China in particular in mind, also as he followed by comparing the West's deep involvement in Ukraine to the Taiwan situation. He then said: "Under these conditions, bilateral relations between Russia and China have surpassed the level of strategic ties in all respects, becoming more than just allied."

While time may soon tell whether or not Ukraine's defenses are "almost exhausted" - it has become very clear that the counteroffensive is not going well, and Biden's 'all in' support to Kiev is becoming politically unpopular and an additional liability for Democrats going into the 2024 presidential election.

Another key part of the Russian defense chief's speech touched on nuclear weapons. He blasted allegations by the West that Putin is ready to use them

"From a military point of view, there is no need to use nuclear weapons in Ukraine to achieve the set goals," Shoigu said at an international security conference in Moscow.

He slammed media speculation that Russia could potentially use nuclear or chemical weapons to compensate for slow progress in its nearly six-month military campaign in Ukraine as "absolute lies."

Alarmist headlines related to the potential for nuclear apocalypse in international press reports grew especially after Moscow moved tactical nuclear weapons into neighboring Belarus. The Kremlin, however, noted the US had long kept nukes in Europe and Turkey under NATO's nuclear-sharing arrangement. Russian officials have also emphasized that nuclear doctrine has not changed.

https://www.zerohedge.com/geopolitical/ukraines-military-resources-are-almost-exhausted-russian-defense-chief-says

Hunter Biden's Lead Criminal Defense Attorney Asks To Withdraw From Case

 Hunter Biden's top criminal defense attorney has asked a federal judge for permission to withdraw from the case after a plea deal unraveled in late July.

Christopher Clark, Hunter's longtime defense attorney, filed a motion with the Delaware judge overseeing Hunter's case on the grounds that he could now be called as a witness in future proceedings, CNN reports.

"Based on recent developments, it appears that the negotiation and drafting of the plea agreement and diversion agreement will be contested, and Mr. Clark is a percipient witness to those issues," reads the Tuesday filing.

Last week federal prosecutors announced that the had reached an impasse on Hunter's plea deal related to tax offenses and a "diversion agreement" to take care of a gun possession charges.

After the deal unraveled, the feds asked Judge Maryellen Noreika to withdraw a late August deadline to renegotiate the plea deal, after she said she was not ready to accept it & asked both sides to file additional briefs explaining the legal structure of the revised deal.

Noreika also called the deal federal prosecutors reached with Hunter over his gun possession offense "unusual," and that it contained some "non-standard terms," such as "broad immunity" from other potential charges.

Under the original plea agreement, Biden intended to plea guilty to two misdemeanor tax crimes committed in 2017 and 2018, and would avoid prison on the gun possession charge.

As part of the conditions for Hunter's release, he must not consume alcohol or prohibited drugs, or possess a firearm, must submit to random drug tests as required, must actively seek employment and not violate any laws.

On Sunday, Biden attorney Abbe Lowell blamed prosecutors for drafting the agreements the judge wouldn't approve.

Biden’s lawyers said Sunday they believed the gun diversion deal was still “valid and binding.” Abbe Lowell, one of the attorneys, placed blame on prosecutors for drafting the agreements the judge took issue with. -CNN

After the plea deal unraveled, US Attorney David Weiss requested and was granted "special counsel" status by Attorney General Merrick Garland.

According to prosecutors, there is still an ongoing investigation which may carry future charges outside the scope of the plea deal.

Biden pleaded guilty to two misdemeanor tax crimes, and will avoid prison charge for possessing a gun while addicted to an illegal drug.

The deal sought to cap a five-year investigation into Hunter's tax affairs and business dealings, which federal prosecutors say Hunter failed to pay over $100,000 of income tax on at least $1.5 million in income between 2017 and 2018.

https://www.zerohedge.com/political/hunter-bidens-lead-criminal-defense-attorney-asks-withdraw-case

Proton Pump Inhibitors Linked to Serious Infection Risk in Children

 Proton pump inhibitors (PPIs) were strongly linked with serious infection risk among infants and young children in a large national study, suggesting caution in prescribing.

In more than one million children followed for approximately 4 years, use of PPIs was associated with a 34% increase in risk for infections requiring hospitalization (HR 1.34, 95% CI 1.32-1.36), said researchers led by Marion Lassalle, PharmD, PhD, of the French National Agency for the Safety of Medicines and Health Products in Saint-Denis.

Excess risk extended to infections in the digestive tract; ear, nose, and throat sphere; lower respiratory tract; kidneys or urinary tract; and nervous system, the group reported in JAMA Pediatrics

opens in a new tab or window.

Risk for bacterial infections was 56% higher (HR 1.56, 95% CI 1.50-1.63) and risk for viral infections was 30% higher (HR 1.30, 95% CI 1.28-1.33) in children who received PPIs compared with those who did not.

"To our knowledge, this is the first study investigating the risk of serious infections associated with PPI use in young children for various sites and pathogens," the researchers said. "Proton pump inhibitors should not be used without a clear indication in this population."

Use of PPIs in young children has been increasing, Lassalle and colleagues noted. In France, 6.1% of children younger than 2 years of age were given PPIs in 2019, up from 3.6% in 2010. In other countries such as Sweden, Norway, and Denmark, use of PPIs in children has increased three- to five-fold since 2000, they said.

Lassalle's group discussed some potential mechanisms for the link between PPIs and infections in children. By altering gastric pH, PPIs may change gastric microbiota in a way that promotes enteric infections. In infancy, the gut microbiota undergoes major changes, and PPI exposure could have a significant impact, they said.

In addition, PPIs could lead to respiratory infections via micro-aspiration of gastric fluid enriched in bacteria or, alternatively, via the gut-lung axis. And PPIs might also interfere with functions of the immune system, including various neutrophil functions, the researchers suggested.

In an accompanying editorialopens in a new tab or window, Jay Berry, MD, MPH, and Jonathan Mansbach, MD, MPH, both of Boston Children's Hospital, said that physicians are increasingly using PPIs to manage healthy infants with gastroesophageal reflux (GER, or "spitting up"), who present with excessive crying and regurgitation.

"Physicians are also using PPIs in children with complex, chronic health conditions to manage suspected GERD," which is GER with complications, they wrote. "While the subset of these children with impaired oromotor function are more likely to have GERD than healthy children, there is no strong evidence to support the use of PPIs in either population. Worse: there may be harm."

Given these "compelling" results as well as the plausible mechanisms, "it is time to limit PPI use in infants and children, especially when they are otherwise healthy and until further investigation distinguishes who has the most favorable risk-benefit ratio," Berry and Mansbach advised.

The nationwide cohort study included all 1.26 million children born in France from 2010 to 2018 who got a first-time treatment prescription for medications that would treat gastric acid-related disorders. About half got PPIs, while the rest got histamine 2 receptor antagonists (H2RAs), or antacids/ alginate between birth and Dec. 31, 2019.

"These drugs share the same indications, so restricting the study population to children receiving these treatments at baseline would mitigate residual confounding," the researchers noted. "Only PPIs dramatically reduce gastric acid secretion and are therefore most likely to lead to infections."

The median age at which a child received PPIs was 88 days (interquartile range 44-282 days). The data came from the Mother-Child EPI-MERES Register, developed from the French National Health Data System, which includes all pregnancies in France since 2010.

The cohort was followed through December 2019. During that time, 152,055 children were newly diagnosed with a serious infection requiring hospitalization. The researchers used Cox models to estimate associations between PPI use and infections, applying a 30-day lag to minimize reverse causality. The researchers also adjusted for sociodemographic factors, pregnancy characteristics, child comorbidities, and healthcare utilization.

They study found increased risk for the following types of infections:

  • Digestive tract (HR 1.52, 95% CI 1.48-1.55)
  • Ear, nose, and throat (HR 1.47, 95% CI 1.41-1.52)
  • Lower respiratory tract (HR 1.22, 95% CI 1.19-1.25)
  • Kidneys or urinary tract (HR 1.20, 95% CI 1.15-1.25)
  • Nervous system (HR 1.31, 95% CI 1.11-1.54)

The study did not include information on breast feeding or social interaction, which are notable risk factors for infection, Lassalle and colleagues noted. In addition, the study did not distinguish between children experiencing GERD from those inappropriately treated for uncomplicated GER, they said.

"PPIs are often prescribed off-label for this indication," they said. "However, their efficacy on crying and irritability, vomiting and regurgitation, or even signs and symptoms of GERD (feeding refusal, chronic cough, or arching) is not demonstrated."

Disclosures

No funding source was indicated for this study. The researchers reported no conflicts of interest.

Berry and Mansbach reported no conflicts of interest.

Primary Source

JAMA Pediatrics

Source Reference: opens in a new tab or windowLassalle M, et al "Proton pump inhibitor use and risk of serious infections in young children" JAMA Pediatr 2023; DOI: 10.1001/jamapediatrics.2023.2900.

Secondary Source

JAMA Pediatrics

Source Reference: opens in a new tab or windowBerry JG, Mansbach JM "Questionable safety of proton pump inhibitor use in children" JAMA Pediatr 2023; DOI: 10.1001/jamapediatrics.2023.2906.


https://www.medpagetoday.com/pediatrics/generalpediatrics/105878